C ATERINA
M USETTI,
P h.D.
Department
of
Chemistry
and
Biochemistry,
Georgia
Institute
of
Technology,
Atlanta
GA
30332
Email:
acc6xq@r.postjobfree.com
Phone:
404.824
6614
O BJECTIVE
Biophysics
expert
seeking
new
opportunities
for
professional
growth
in
a
pharmaceutical,
medical
or
biotech
environment.
Q UALIFICATIONS
Strong
expertise
in
advanced
analytical,
biophysical
chemistry
and
molecular
biology
techniques
to
•
identify
and
address
challenging
questions
in
the
field
of
drug
discovery
and
development.
Target
identification
and
ligand
validation,
lead
compound
optimization,
characterization
of
•
macromolecular
complexes
and
their
interaction
kinetics
and
thermodynamics.
Ability
to
work
effectively
in
a
team
environment.
Strong
interpersonal
skills.
Quick
adaptability
for
•
new
techniques
and
environments.
Understanding
of
regulatory
documents
preparation.
•
R ESEARCH
S KILLS
Spectroscopy:
UV-
Visible,
Fluorescence,
FRET,
Circular
Dichroism,
Thermal
denaturation.
•
Surface
Plasmon
Resonance
(SPR):
Biacore
•
Calorimetry:
Isothermal
(ITC)
and
Differential
Scanning
Calorimetry
(DSC).
•
Chromatography:
RP-
HPLC,
Size
exclusion,
Ion
exchange,
LC-
MS.
•
PCR
•
Mass
Spectrometry:
ESI
and
MALDI.
•
Gel
electrophoresis:
PAGE,
SDS
PAGE,
Agarose,
Western
blot.
•
DNA
Radiolabelling
•
Enzyme
inhibition
assays
•
Pre-
formulation
studies:
pka,
partition
coefficients,
pH
solubility
profiles,
dissolution
assay.
•
Informatics
skills:
Windows
and
Mac
OS,
Excel,
Word,
Power
Point,
Sigma
plot,
Kaleidagraph,
Igor,
ISIS
•
Draw,
Chem
Draw.
Knowledge
and
ability
to
use
scientific
databases
(Beilstein
and
Scifinder)
E DU CATION
M.S.
Pharmaceutical
Biotechnology
University
of
Padova
(Italy)
2013
•
Ph.D.
Biomedicine
University
of
Padova
(Italy)
2011
•
M.S.
Chemistry
Georgia
State
University,
Atlanta
(GA)
2010
•
M.S.
Pharmaceutical
Chemistry
and
Technologies
University
of
Padova
(Italy)
2005
•
P ROFESSIONAL
E XPERIENCE
POSTDOCTORAL
ASSOCIATE
Georgia
Institute
of
Technology,
Atlanta,
GA
Feb
2013
–
Present
(fellowship
supported
by
NASA
Exobiology)
• An
ongoing
project
aimed
to
challenge
the
potential
of
small
molecules
(intercalators)
to
promote
the
assembly
of
nucleic
acids
containing
alternative
backbones.
• Investigating,
by
CD
and
UV
spectroscopy,
the
folding
and
stability
of
nucleic
acids
in
non
aqueous
media
(Deep
Eutectic
Solvents).
POSTDOCTORAL
ASSOCIATE
University
of
Padova,
Italy
Mar
2011
–Dec
2012
(fellowship
supported
by
AIRC,
Italian
Association
for
Cancer
Research)
• Identified
and
characterized,
using
UV,
CD
and
mass
spectrometry,
the
psoralen
moiety
as
a
new
scaffold
for
G-
quadruplex
DNA
targeting
with
potential
relevance
for
anticancer
treatment.
Investigated
the
energetics
of
interaction
of
a
metal
complex
with
distinct
G-
quadruplex
DNA
•
structures
formed
in
the
human
telomere
using
ITC
and
Circular
Dichroism.
• Characterized,
by
mass
spectrometry
and
SDS
PAGE,
the
reactivity
profile
of
transplatin
derivatives
towards
model
proteins
and
successfully
demonstrated
protein
oligomerization
occurring
through
compound
mediated
cross-
linking.
SCIENTIFIC
CONSULTANT
Fyton
Wellness
Srl,
Verona,
Italy
Jan
2011
–
Dec
2012
• Created
and
formulated
a
new
line
of
nutritional
supplements
currently
in
production
(www.fyton.it).
DOCTORAL
CANDIDATE
University
of
Padova,
Italy
Jan
2008-
Mar
2011
• Developed
new
efficient
and
selective
telomerase
inhibitors,
endowed
with
pharmacological
activity.
• Investigated
the
DNA
binding
properties
of
phenantroline
derivatives
in
presence/absence
of
transition
metals
and
showed
how
different
complex
geometries
can
affect
the
pattern
of
DNA
recognition.
• Defined
the
ability
of
transplatin
amine
derivatives
to
form
DNA-
adducts,
their
reactivity,
the
nature
and
kinetics
of
adduct
formation
with
distinct
DNA
targets.
• Part
of
the
Ph.
D.
research
was
completed
Georgia
State
University,
in
the
lab
headed
by
Dr.
David
Wilson,
focusing
on
quantitative
evaluation
of
heterocyclic
cations-
DNA
interaction
by
biosensor-
surface
plasmon
resonance,
spectroscopic
and
calorimetric
techniques.
GRADUATE
FELLOW
University
of
Padova,
Italy
Jan
2007-
Dec
2007
• Synthesized
and
characterized
by
HPLC
and
gel
electrophoresis,
polymers
of
DNA
bases
(analogues
of
the
drug
Defibrotide)
as
potential
anticoagulant
agents.
PHARMACIST
Farmacia
Martini,
Verona,
Italy
Jan
2006-
Dec
2006
• Work
required
processing
of
prescriptions,
patient
counseling,
preparation
of
galenic
medications.
UNDERGRADUATE
FELLOW
GlaxoSmithKline,
Verona,
Italy
Apr
2005-
Oct
2005
• Developed
a
USP
II
based
dissolution
test
using
fasted
(FaSSIF)
and
fed
states
(FeSSIF)
simulating
media
for
qualitative
forecasting
of
formulation
and
food
effects
on
the
availability
of
a
poorly
soluble
weak
base
drug.
SUMMER
INTERN
GlaxoSmithKline,
Verona,
Italy
Summer
2003
• Sampled
and
tested
raw
materials
for
stability
control
and
evaluation
of
the
most
common
excipients
used
by
the
company.
• Assisted
senior
analytical
chemists
and
technicians
in
daily
operation
of
lab
activities.
L ANGUAGES
Fluent
in
spoken
and
written
English
and
Italian.
•
R ESPONSIBILITIES,
A WARDS
A ND
A FFILIATIONS
Records
of
productivity
in
advanced
scientific
writing
as
well
as
effective
communication
and
•
presentation
skills.
Trained
and
mentored
several
graduate
and
undergraduate
students.
Teaching
assistant
experience
in
•
chemistry
laboratory
classes.
Reviewed
manuscripts
for
internationally
recognized
journals.
•
“Doctor
Europaeus”
Mention
(2011).
•
Biennial
post-
doctoral
fellowship
“Gabriele
Santoro”
grant,
awarded
by
Associazione
Italiana
per
la
•
Ricerca
sul
Cancro
(2010).
COST
Action
MP0802
grant
for
Training
School
within
the
COST
scientific
program
on
“Self-
assembled
•
guanosine
structures
for
molecular
electronic
devices”
(2011).
Graduate
fellowship
grant
“Synthesis
of
analogues
of
Defibrotide”,
awarded
by
Gentium
SpA
(2007).
•
Member
of
American
Chemical
Society,
Italian
Chemical
Society
and
American
Association
for
Cancer
•
Research.
P UBLICATIONS
( S E LECTED )
Pinato,
O.;
Musetti,
C.;
Sissi,
C.;
“Pt-
based
drugs:
the
spotlight
will
be
on
proteins”
(2013)
Metallomics,
•
Review
paper,
in
press
Bianco,
S.;
Musetti,
C.;
Krapcho,
A.
P.;
Palumbo,
M.;
Sissi,
C.;
“Ni2+
and
Cu2+
complexes
of
•
phenathroline-
based
ligand
bind
to
G-
quadruplex
at
non
overlapping
sites”,
ChemComm
(2013),
49,
8057-
8059.
Musetti,
C.;
Krapcho,
A.
P.;
Palumbo,
M.;
Sissi,
C.;
“Effect
of
G-
quadruplex
polymorphism
on
the
•
recognition
of
telomeric
DNA
by
a
metal
complex”,
PlosOne
(2013),
8
(3):
e58529.
Pinato,
O.;
Musetti,
C.;
Farrell,
N.;
Sissi,
C.;
“Platinum
based
drugs
and
proteins:
reactivity
and
•
relevance
to
DNA
adduct
formation”,
Journal
of
Inorganic
Biochemistry
(2013),
122:
27-
37.
Alcaro,
S.;
Musetti,
C;
Distinto,
S.;
Artese,
A.;
Parrotta,
L.;
Moraca,
F.;
Costa,
G.;
Ortuso,
F.;
Maccioni,
•
E.;
Sissi,
C.:
“Identification
and
characterization
of
new
DNA
G-
quadruplex
binders
selected
by
a
combination
of
ligand
and
structure-
based
virtual
screening
approaches”.
J.Med.Chem
(2013),
56
(3):
843-
855.
Nanjunda,
R.;
Musetti,
C.;
Kumar,
A.;
Ismail,
M.
A.;
Farahat,
A.
A.;
Wang,
S.;
Sissi,
C.;
Palumbo,
M.;
•
Boykin,
D.
W.;
Wilson,
D.
W.
“Heterocyclic
Dications
as
a
New
Class
of
Telomeric
G-
Quadruplex
Targeting
Agents”.
Current
Pharmaceutical
Design.
(2012),
18(14):
1934-
1947.
Musetti,
C.;
Bianco,
S.;
Krapcho,
A.
P.;
Palumbo,
M.;
Sissi,
C.
“Differential
binding
mode
of
a
•
phenanthroline-
base
metal
complex
to
a
DNA
or
RNA
telomeric
sequence”.
International
Review
of
Biophysical
Chemistry.
(2011),
2
(4).
Musetti,
C,
Nazarov,
A.
A.;
Farrell,
N.
P.;
Sissi,
C.
“DNA
Reactivity
Profile
of
trans-
Platinum
Planar
Amine
•
Derivatives”.
ChemMedChem.
(2011),
6
(7):
1283-
1290.
Bianco,
S.;
Musetti,
C.;
Sparapani,
J.
D.;
Krapcho,
A.
P.;
Palumbo,
M.;
Sissi,
C.
“
Bis-
phenanthroline
•
derivatives
as
suitable
scaffolds
for
effective
G-
quadruplex
recognition”.
Dalton
Trans.,
(2010),
39:
5833-
5841
Musetti,
C.;
Lucatello,
L.;
Bianco,
S.;
Krapcho,
A.
P.;
Cadamuro,
S.
A.;
Palumbo,
M.;
Sissi,
C.
“Metal-
ion
•
mediated
assembly
of
effective
phenanthroline-
based
G-
quadruplex
ligands”.
Dalton
Trans.,
(2009),
19:
3657-
3670.
C ONFERENCE
P RESENTATIONS
A ND
P OSTERS
18
posters
and
5
oral
presentations
in
several
national,
international
and
local
scientific
conferences.
•